Navigation Links
$250,000 Grant Awarded to National Hospice and Palliative Care Organization from Technology Grant Program
Date:4/9/2008

ALEXANDRIA, Va. and SUNNYVALE, Calif., April 9 /PRNewswire/ -- The National Hospice and Palliative Care Organization announced today that it has received a cash grant of $250,000 from a court-approved fund benefiting non-profit organizations in health care, the arts, education and underserved populations.

NHPCO will apply this unrestricted grant to increase online and web-based educational opportunities for hospice professionals, support research and policy about quality hospice and palliative care provision, and help expand public understanding of the benefits of quality end-of-life care.

This new grant comes the very week NHPCO is launching its new, expanded online educational portal for professionals. This new Internet-based resource -- unlike existing training opportunities in the field -- will provide online courses offering continuing education credits to a range of professionals. Online learning modules will include clinical topics, management and leadership offerings, and sessions designed to increase capacity of the hospice interdisciplinary team.

Additional support will also be available to ongoing research initiatives, NHPCO's Quality Partners program that is helping providers build organizational excellence and improve patient outcomes, and Caring Connections, NHPCO's consumer focused initiative that provides information on hospice, advance care planning, family caregiving and more.

"This funding and earlier grants of Fujitsu technology are essential as we support initiatives to educate and train professionals, expand research about care at the end of life, and increase awareness of quality hospice and palliative care and work to ensure that all people who can benefit from the services hospices provide will have access," said J. Donald Schumacher. "Our deep appreciation goes out to Fujitsu."

This generous award reflects the ongoing interest and support that Fujitsu has had for hospice and palliative care provisio
'/>"/>

SOURCE Fujitsu Computer Products of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Covington, VA Man Wins $250,000 for Losing 125 Pounds
2. Woman from Kirksville, MO Wins $250,000 for Losing Weight and Beating Hypertension
3. Hooters of Gulfport Makes the Largest Contribution towards the $250,000 Donation to the V Foundation for Cancer Research
4. Dynatronics Announces $250,000 Increase in Stock Buyback Program
5. Red Cross Receives $250,000 From Wal-Mart to Assist With Southern California Wildfire Relief Efforts
6. Wal-Mart Foundation Provides Brenau University $250,000 Health Care scholarships Grant for Hispanic Women
7. DuPont Pledges $250,000 to Nature Conservancy for Water Quality Initiative
8. The Fresh Market Raises Over $250,000 for Juvenile Diabetes Research Foundation
9. Arthritis Foundation Grants Ease-Of-Use Commendation to Duracell EasyTab Hearing Aid Battery
10. Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine
11. Children of New Bedford Immigrant Raids Are Victims of Terrorism, Testifies Dr. Laria Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... therapies for preterm labor , , FRIDAY,...ve found the switch that activates the uterine mus...that may lead to therapies for preterm labor. ,...tein IP on the surface of these uterine muscle cel...ncy. , But researchers from Dartmouth Medical ...
(Date:11/21/2008)...The University of Texas Health Science Center at H...nce in Aging Studies (TEXAS), to promote geriatric... million award from the Donald W. Reynolds Foundat...ill allow us to teach geriatric medicine principle... to practicing physicians. With the reach of Lyndo...
(Date:11/21/2008)... The Generic,Pharmaceu...atement today from,GPhA President and CEO Kathlee...FTC) roundtable on "Emerging Health Care Competiti...hat the FTC is conducting this roundtable demonstr...nsumers have access to safe and,affordable biogen...
(Date:11/21/2008)...swire-USNewswire/ -- The University of Texas M. ...a collaborative effort to eradicate breast cancer ...r Awareness and Research of the Americas today at ...ited States, and Vivian Fernandez de Torrijos, the...derson in the initiative are the U.S. Department o...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...hat laughter brings out the humanitarian facet and...excellent therapeutic aid//. This research was con...ersity of Kent. People who were involved in this... a serious video followed by a game with total str...
... minister Manto Tshabalala-Msimang who has undergo... announced// by the minister’s medical team. Prof...t at the Johannesburg Hospital and Wits University...is liver transplant very urgently and that she did...
... over with early stage breast cancer who do not ha...isk of a local recurrence// or development of a ne...ed with breast cancer are sixty-five and over. Pas...are less likely to be offered chemotherapy, hormon...
...e respiratory syndrome (SARS) epidemic in China ha... spread of other respiratory diseases// , accordin...of Clinical Infectious Diseases, currently availab...of SARS transmission in Guangzhou province and Hon...
Other Medicine News:Health News:Study Identifies Risk Factors for Spread of Respiratory Infections in Hospitals 2
(Date:11/19/2008)...rstCall/ -- Amgen,(Nasdaq: AMGN ) and Millenniu...akeda Pharmaceutical Company Limited (TSE: 4052), ...NET1 trial evaluating motesanib (AMG 706) in,comb...rst-line treatment of,advanced non-small cell lun...ollowing a planned safety data review of 600 patie...
(Date:11/19/2008)...iotech scientists increasingly are applying genomi...nderstand the effects of novel drug candidates on ...eering & Biotechnology News ( GEN ). They are...und,s mechanism of action and eventually developin...the November 15 issue of GEN . ( http://www.genen...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...e/ -- Forty-two leading U. S. scientists and speci...nsider cutting-edge innovations that may defend Am...tbreaks of dangerous zoonotic diseases, the FAZD C...vations: , , , , A "Doc in a Bo...ghly contagious and dangerous zoonotic diseases in...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 1The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 3The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 4Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 1Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 2Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 3Nestle Nutrition and Phosphagenics to Commence Phospha E 28R 29 Phase 2 Clinical Trial 447 4Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 1Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 2Malaria product portfolio would benefit from greater cohesion amongst stakeholders 2866 3Majority of Americans want local action on global warming says poll 673 1Majority of Americans want local action on global warming says poll 673 2
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Ammonia reagent is used for the quantitative and enzymatic determination of ammonia in human plasma.
The Proteomeworks system is an integrated set of tools and technologies that enables protein function discovery. Innovative new tools for sample preparation, 2-D electrophoresis, staining, imaging an
Medicine Products: